Qing Wang,Ya Gao,Yanzheng Chen,Xuan Wang,Qingguo Pei,Taiyu Zhang,Changping Wang,Jinsong Pan
Bone implant-associated infections and inflammations, primarily caused by bacteria colonization, frequently result in unsuccessful procedures and pose significant health risks to patients. To mitigate these challenges, the development of engineered implants with spatiotemporal regulation capabilities, designed to inhibit bacterial survival and modulate immune responses in the early stage, while promoting bone defect healing in the late stage is proposed. The implants are functionalized with ε-poly-l-lysine-phenylboronic acid (PP) via dynamic boronic ester bonds, which facilitate its release through a reactive oxygen species (ROS) and pH-responsive strategy, thereby establishing an antibacterial microenvironment on and around the implants. Additionally, the dynamic metal coordination interaction facilitates the loading and sustained release of Sr 2+ under an acidic environment, providing immunomodulatory and osteogenic effects. The ROS/pH-responsive feature, coupled with the implant-bone tissue integration process, affords precise spatiotemporal regulation of the Ti-TA-Sr-PP implants. This strategy represents a promising approach for the preparation of advanced bone implants.
This study focuses on an injectable hydrogel for osteoarthritis (OA) therapy. We developed a reactive oxygen species (ROS)/pH-responsive self-healing hydrogel loaded with icariin-PLGA nanoparticles (ICA NPs-HG), demonstrating >30-day joint retention, synergistic ROS scavenging via ICA-borate bond interactions, and dual anti-inflammatory and antioxidative therapeutic effects in vivo. This system, based on a borate/diol cross-linked network, addresses the challenge of hydrogel damage under mechanical force and offers significant potential for OA treatment.